IONTAS Limited, headquartered in Great Britain, is a leading biotechnology company specialising in the development of innovative antibody discovery and engineering solutions. Founded in 2008, IONTAS has established itself as a key player in the biopharmaceutical industry, with a focus on providing high-quality services to clients in the therapeutic antibody space. The company is renowned for its proprietary technologies, including its unique phage display platform, which enables the rapid identification and optimisation of antibodies. IONTAS has achieved significant milestones, including collaborations with major pharmaceutical companies and successful advancements in therapeutic development. With a commitment to excellence and a strong market position, IONTAS Limited continues to drive innovation in antibody therapeutics, making it a trusted partner for organisations seeking cutting-edge solutions in drug development.
We don't have data for IONTAS Limited, but we can show you information about their parent organization instead.
View parent company